Bicara Therapeutics Inc（BCAX）价格预测

$17.610

-0.296 (-1.68%)收盘时

价格预测

1-Day Price Prediction

-4.68%

1-Week Prediction

-0.51%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中打开以解锁更长周期的预测。

Loading chart…

BCAX 相似图表分析预测

Alphio's BCAX stock price prediction model matches the current Bicara Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $16.79 (-4.68%). The 1-week path is $17.52 (-0.51%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

该买入 Bicara Therapeutics Inc 股票吗？

Bicara Therapeutics Inc is not a good buy right now due to its current price of $16.78, which is significantly below the analyst price targets ranging from $20 to $39. However, the recent RSI of 29.34 indicates that the stock is oversold, suggesting potential for a rebound. The primary risk is the company's ongoing net losses, with a reported loss of $56.2 million in Q1 2026, which raises concerns about its financial sustainability.

BCAX 股价于 Thursday 收于 $17.61，此前下跌 -1.68%

Bicara Therapeutics Inc (BCAX) last closed at $17.61, losing -1.68%. These facts feed the 1-day and 1-week BCAX price prediction above.

预测驱动因素

Bicara Therapeutics Inc（BCAX）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。

Similar patterns

Positive

Bullish

Seasonality

Positive

Bullish

SMA 20

Positive

Bullish

SMA 200

Negative

Bearish

相似图表形态

近期走势与 BCAX 最接近的股票，按相似度排序。

WEN

91.66%

+5.72%

ACHC

91.49%

-26.29%

91.10%

+1.37%

TSLA

91.02%

+93.00%

MYGN

90.98%

-7.41%

BCAX 季节性分析

Historically the probability of a positive October return for BCAX is 61.90%. October offers the highest probability of a positive month at 61.90%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…